Similar articles

• Rapamycin: something old, something new, sometimes borrowed and now renewed.

  Hartford CM, Ratain MJ. Hartford CM, et al. Clin Pharmacol Ther. 2007 Oct;82(4):381-8. doi: 10.1038/sj.clpt.6100317. Epub 2007 Aug 29. Clin Pharmacol Ther. 2007. PMID: 17728765 Review.
• Proteasome inhibition by peptide-semicarbazones.

  Leban J, Blisse M, Krauss B, Rath S, Baumgartner R, Seifert MH. Leban J, et al. Bioorg Med Chem. 2008 Apr 15;16(8):4579-88. doi: 10.1016/j.bmc.2008.02.042. Epub 2008 Feb 15. Bioorg Med Chem. 2008. PMID: 18313310
• Synthesis and structure-immunosuppressive activity relationships of bakuchiol and its derivatives.

  Chen H, Du X, Tang W, Zhou Y, Zuo J, Feng H, Li Y. Chen H, et al. Bioorg Med Chem. 2008 Mar 1;16(5):2403-11. doi: 10.1016/j.bmc.2007.11.054. Epub 2007 Nov 28. Bioorg Med Chem. 2008. PMID: 18063371
• Sanglifehrin-cyclophilin interaction: degradation work, synthetic macrocyclic analogues, X-ray crystal structure, and binding data.

  Sedrani R, Kallen J, Martin Cabrejas LM, Papageorgiou CD, Senia F, Rohrbach S, Wagner D, Thai B, Jutzi Eme AM, France J, Oberer L, Rihs G, Zenke G, Wagner J. Sedrani R, et al. J Am Chem Soc. 2003 Apr 2;125(13):3849-59. doi: 10.1021/ja021327y. J Am Chem Soc. 2003. PMID: 12656618
• Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.

  Bierer BE. Bierer BE. Proc Assoc Am Physicians. 1995 Apr;107(1):28-40. Proc Assoc Am Physicians. 1995. PMID: 8630742 Review. No abstract available.